Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer

Showing results (91-100 of 41,506) with videos related to

Pageof 4,151
Sort By:
Cancer|October 21, 2010
The selective Trk inhibitor AZ623 inhibits brain-derived neurotrophic factor-mediated neuroblastoma cell proliferation and signaling and is synergistic with topotecanPeter E Zage, Timothy C Graham, Lizhi Zeng, et al.
Cancer|October 21, 2010
Association of hyaluronic acid family members (HAS1, HAS2, and HYAL-1) with bladder cancer diagnosis and prognosisMario W Kramer, Diogo O Escudero, Soum D Lokeshwar, et al.
Cancer|October 21, 2010
Monitoring molecular response in chronic myeloid leukemiaJorge Cortes, Alfonso Quintás-Cardama, Hagop M Kantarjian
Cancer|October 21, 2010
Editorial for "Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50"Gerald L Andriole, Adam S Kibel
Cancer|October 21, 2010
Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphomaAntonino Musolino, Daniela Boggiani, Michele Panebianco, et al.
Cancer|December 21, 2010
A "natural" in the hunt for anticancer compounds. Researcher spans the globe in quest for cancer-fighting plantsCarrie Printz
Cancer|December 21, 2010
Stage of breast cancer at diagnosis among low-income women with access to mammographyRebecca Lobb, John Z Ayanian, Jennifer D Allen, et al.
Cancer|February 18, 2011
Rapid early monoclonal protein reduction after therapy with bortezomib or bortezomib and pegylated liposomal doxorubicin in relapsed/refractory myeloma is associated with a longer time to progressionJatin Shah, Joan Bladé, Pieter Sonneveld, et al.
Cancer|February 18, 2011
Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancerJin-hong Park, Sang Min Yoon, Chang Sik Yu, et al.
Cancer|March 3, 2011
Turning conventional wisdom upside-down: low serum testosterone and high-risk prostate cancerAbraham Morgentaler
Pageof 4,151

Showing results (91-100 of 41,506) with videos related to

Sort By:
Pageof 4,151
Cancer|October 21, 2010
The selective Trk inhibitor AZ623 inhibits brain-derived neurotrophic factor-mediated neuroblastoma cell proliferation and signaling and is synergistic with topotecanPeter E Zage, Timothy C Graham, Lizhi Zeng, et al.
Cancer|October 21, 2010
Association of hyaluronic acid family members (HAS1, HAS2, and HYAL-1) with bladder cancer diagnosis and prognosisMario W Kramer, Diogo O Escudero, Soum D Lokeshwar, et al.
Cancer|October 21, 2010
Monitoring molecular response in chronic myeloid leukemiaJorge Cortes, Alfonso Quintás-Cardama, Hagop M Kantarjian
Cancer|October 21, 2010
Editorial for "Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50"Gerald L Andriole, Adam S Kibel
Cancer|October 21, 2010
Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphomaAntonino Musolino, Daniela Boggiani, Michele Panebianco, et al.
Cancer|December 21, 2010
A "natural" in the hunt for anticancer compounds. Researcher spans the globe in quest for cancer-fighting plantsCarrie Printz
Cancer|December 21, 2010
Stage of breast cancer at diagnosis among low-income women with access to mammographyRebecca Lobb, John Z Ayanian, Jennifer D Allen, et al.
Cancer|February 18, 2011
Rapid early monoclonal protein reduction after therapy with bortezomib or bortezomib and pegylated liposomal doxorubicin in relapsed/refractory myeloma is associated with a longer time to progressionJatin Shah, Joan Bladé, Pieter Sonneveld, et al.
Cancer|February 18, 2011
Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancerJin-hong Park, Sang Min Yoon, Chang Sik Yu, et al.
Cancer|March 3, 2011
Turning conventional wisdom upside-down: low serum testosterone and high-risk prostate cancerAbraham Morgentaler
Pageof 4,151